BookSanchia S. Goonewardene, Karen Ventii, Amit Bahl, Raj Persad, Hanif Motiwala, David Albala.
Summary: This book provides a systematic review of the management and treatment of this disease. The concise and highly structured chapters feature essential background knowledge and commentary on recent advances within each step of a range of patient pathways. Management of Muscle Invasive Bladder Cancer provides a framework for patients' care based on the research, as well as practically and clinically oriented guidelines. This book is relevant to trainees and practicing urologists and oncologists, in addition to medical professionals involved in the treatment of bladder cancer.
Contents:
1. Introduction to muscle invasive bladder cancer
2. Epidemiology and risk factors in muscle invasive bladder cancer
3. The molecular basis of muscle invasive bladder cancer
4. Histological variants in MIBC
squamous cell and squamous differentiation
5. Histological variants in muscle invasive bladder cancer - adenocarcinoma
6. Histological variants in muscle invasive bladder Cancer
sarcomatoid cancer
7. MIBC Carcinosarcoma
8. Muscle invasive bladder cancer- small cell
9. MIBC plasmacytoid
10. MIBC and micropapillary bladder cancer
11. MIBC bladder cancer assessment and diagnosis
12. A systematic review on blue light cystoscopy in bladder cancer diagnostics
13. A systematic review on the staging conundrum in bladder cancer
14. Current state of investigations and limitations in muscle invasive bladder cancer
15. Risk stratification in bladder cancer
16. Preventative measures for those with high risk MIBC
17. Bladder cancer risk post pelvic irradiation
18. A systematic review on bladder preservation strategies and MIBC
19. Partial cystectomy
20. Muscle invasive bladder cancer and neoadjuvant chemotherapy
21. Controversies in clinical effectiveness of neoadjuvant chemotherapy
22. Trimodal therapy in bladder cancer
23. Systematic review on trimodal therapy in bladder cancer
24. Trimodal therapy
a systematic review
25. Reviews related to trimodal therapy for MIBC
26. Radical cystectomy lap open robotic
27. Prostate sparing cystectomy
a systematic review
28. A systematic review on nerve sparing cystoprostatectomy
29. MIBC
orthotopic vs ileal conduit
30. MIBC
a systematic review on orthotopic neobladder vs. ileal conduit
31. MIBC and radical cystectomy in the elderly
32. MIBC radical radiotherapy
33. MIBC
quality of life with urinary diversion
34. Neoadjuvant chemotherapy for muscle invasive bladder cancer
35. Muscle invasive bladder cancer and the staging conundrum
36. Radical cystectomy outcomes
37. Muscle Invasive bladder cancer and neoadjuvant chemotherapy
38. Muscle invasive bladder cancer and the staging conundrum
39. Physical pre-habilitation prior to radical cystectomy
40. Exercise therapy pre surgery
41. Patient fitness for surgery
42. CPEX testing prior to major urological surgery
43. Cardio-pulmonary exercise testing and major urological surgery
44. Robotic radical cystectomy and enhanced recovery
45. The robotic approach to redo surgery
46. Robotic cystectomy and intracorporeal neobladder formation
47. Secondary pelvic malignancies and bladder cancer
48. Organ sparing cystectomy
49. Robotic radical cystectomy
50. Robotic cystectomy and intracorporeal stoma formation
51. Orthotopic neobladders vs. ileal conduits
52. The role of enhanced recovery in robotic cystectomy
53. Robotic radical cystectomy and lymph node dissection
54. Robotic cystectomy and sentinel node mapping
55. Robotic radical cystectomy and intracorporeal stoma formation
56. Lap vs open vs robotic cystectomy
57. A systematic review on obesity in bladder cancer
58. Systematic review results on obesity in bladder cancer
59. Reviews on BMI and bladder cancer
60. Survivorship Issues in muscle invasive bladder cancer
61. Muscle invasive bladder cancer and health related quality of life
62. Body image in bladder cancer
63. The rationale for neoadjuvant chemotherapy
64. Support for partners in bladder cancer.